- Home
- DRRX vs CODX Comparison
DRRX vs CODX Comparison
Compare DRRX & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- CODX
- Stock Information
- Founded
- DRRX 1998
- CODX 2013
- Country
- DRRX United States
- CODX United States
- Employees
- DRRX N/A
- CODX N/A
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- CODX Medical/Dental Instruments
- Sector
- DRRX Health Care
- CODX Health Care
- Exchange
- DRRX Nasdaq
- CODX Nasdaq
- Market Cap
- DRRX 44.4M
- CODX 39.3M
- IPO Year
- DRRX 2000
- CODX 2017
- Fundamental
- Price
- DRRX $1.01
- CODX $1.06
- Analyst Decision
- DRRX Buy
- CODX Hold
- Analyst Count
- DRRX 2
- CODX 1
- Target Price
- DRRX $5.00
- CODX $1.50
- AVG Volume (30 Days)
- DRRX 68.2K
- CODX 77.0K
- Earning Date
- DRRX 11-13-2024
- CODX 11-07-2024
- Dividend Yield
- DRRX N/A
- CODX N/A
- EPS Growth
- DRRX N/A
- CODX N/A
- EPS
- DRRX N/A
- CODX N/A
- Revenue
- DRRX $8,594,000.00
- CODX $7,321,012.00
- Revenue This Year
- DRRX N/A
- CODX N/A
- Revenue Next Year
- DRRX $3.07
- CODX N/A
- P/E Ratio
- DRRX N/A
- CODX N/A
- Revenue Growth
- DRRX N/A
- CODX 57.16
- 52 Week Low
- DRRX $0.48
- CODX $1.00
- 52 Week High
- DRRX $1.88
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- DRRX 26.89
- CODX 30.68
- Support Level
- DRRX $1.27
- CODX $1.11
- Resistance Level
- DRRX $1.36
- CODX $1.19
- Average True Range (ATR)
- DRRX 0.11
- CODX 0.05
- MACD
- DRRX -0.04
- CODX -0.01
- Stochastic Oscillator
- DRRX 2.62
- CODX 5.11
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.